MRK

Recent Articles

Merck & Co., Inc. Features Slow and Steady Dividend Growth (MRK)

Merck is a blue-chip dividend stock that may be a solid investment, however MRK's dividend growth lags other competitors More 

Merck & Co., Inc. (MRK) Preps for a Healthy Breakout

The price action in Merck is mega-bullish and that means there are some cheap ways to try for big rewards in MRK stock. More 

10 Pharmaceuticals Stocks to Buy Now

The grades of 10 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More 

6 Pharmaceuticals Stocks to Buy Now

The grades of 6 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More 

These 62 Big Blue Chips Are on the Move (ABEV, ALL, BLK, HRS)

It pays to stay on top of the latest profit opportunities, and today's blog post updates stock ratings in my Portfolio Grader More 

Bristol-Myers Squibb Co: The BMY Freefall Is Overdone

BMY stock has sustained a technical beatdown over the past couple of days. But Bristol-Myers Squibb is arriving at promising support. More 

3 Big Stock Charts for Friday: Bristol-Myers Squibb Co (BMY), Merck & Co., Inc. (MRK) and Fitbit Inc (FIT)

Huge news changes the technical outlook for Merck (MRK) and Bristol-Myers (BMY) while the long-term picture favors the bulls for Fitbit (FIT). More